Fluorescence resonance energy transfer assays for sarco/endoplasmic reticulum calcium atpase and phospholamban
Provided herein are methods for identifying molecules capable of modulating SERCA, the SERCA-PLB complex or the microenvironment of the complex. An exemplary assay provided herein is fluorescence resonance energy transfer (FRET). Also provided herein are FRET assays that are optimized for high-throughput screening (HTS) for identifying small molecules that modulate SERCA or the SERCA-PLB complex. Further provided are kits for carrying out said methods for identifying molecules.
1. A method for identifying a compound that modulates Sarco/Endoplasmic Reticulum Calcium ATPase (SERCA), comprising:
(a) providing, in the presence of one or more lipids, SERCA labeled with a first chromophore at a first position and a second chromophore at a second position, wherein the second position is different from the first position, wherein the first and the second chromophores can be used for Fluorescence Resonance Energy Transfer (FRET), and wherein the method is suitable for high-throughput screening (HTS);
(b) exciting either the first or the second chromophore; and
(c) measuring FRET between the chromophores;
wherein a difference between FRET in the presence of a test compound and FRET in the absence of the test compound indicates that the test compound modulates SERCA, such that the energy transfer between the two chromophores is altered.
2. The method of claim 1 , wherein the method is performed in the presence of phospholamban (PLB).
3. A method for identifying a compound that modulates the SERCA-PLB complex or its microenvironment, comprising:
(a) providing SERCA labeled with a first chromophore;
(b) providing PLB labeled with a second chromophore, wherein the PLB is WT-PLB or a PLB derivative that gives a functional potency and FRET potency suitable for HTS, and wherein the chromophores can be used for energy transfer;
(c) contacting the SERCA of step (a) with the PLB of step (b) in the presence of a test compound and one or more lipids;
(d) exciting either the first or the second chromophore; and
(e) measuring FRET between the chromophores;
wherein a difference between FRET in the presence of the test compound and FRET in the absence of the test compound indicates that the test compound modulates the SERCA-PLB complex or its microenvironment, such that the energy transfer between the two chromophores is altered.
4. The method of claim 2 , wherein the molar ratio of SERCA to PLB ranges from about 1 to 10 to about 10 to 1.
5. The method of claim 3 , wherein the molar ratio of SERCA to PLB ranges from about 1 to 10 to about 10 to 1.
6. The method of claim 1 , wherein the SERCA is at a concentration ranging from about 1 nM to about 200 μM.
7. The method of claim 2 , wherein the SERCA is at a concentration ranging from about 1 nM to about 200 μM.
8. The method of claim 3 , wherein the SERCA is at a concentration ranging from about 1 nM to about 200 μM.
9. The method of claim 2 , wherein the PLB is at a concentration ranging from about 1 nM to about 200 μM.
10. The method of claim 3 , wherein the PLB is at a concentration ranging from about 1 nM to about 200 μM.
11. The method of claim 3 , wherein the PLB derivative comprises one or more of amino acid modifications relative to WT-PLB, and wherein the amino acid substitutions are one or more of substitution of serine to glutamate at position 16, substitution of leucine to alanine at position 31, substitution of cysteine to alanine at position 36, substitution of isoleucine to alanine at position 40 and substitution of cysteine to phenylalanine at position 41.
12. The method of claim 1 , wherein the first chromophore is labeled on a cysteine residue, and wherein the second chromophore is labeled on a lysine residue.
13. The method of claim 2 , wherein the first chromophore is labeled on a cysteine residue, and wherein the second chromophore is labeled on a lysine residue.
14. The method of claim 3 , wherein the first chromophore is labeled on a cysteine residue, and wherein the second chromophore is labeled on a lysine residue.
15. The method of claim 1 , wherein the first chromophore is N,N,N′,N′-tetramethyl-6-carboxyrhodamine, 5-((((2-iodoacetyl)amino)ethyl)amino) naphthalene-1-sulfonic acid (IAEDANS) and the second chromophore is 4-((4-(dimethylamino)phenyl)azo)benzoic acid (DABCYL) or 2′-(or-3′)-0-(trinitrophenyeadenosine 5′-diphosphate (TNP-ADP).
16. The method of claim 2 , wherein the first chromophore is IAEDANS and the second chromophore is DABCYL or TNP-ADP.
17. The method of claim 3 , wherein the first chromophore is IAEDANS and the second chromophore is DABCYL or TNP-ADP.
18. The method of claim 2 , wherein the method is performed in the presence of one or more lipids, wherein the molar ratio of lipids to PLB to SERCA is about 100-6000 to 1-10 to 1-10.
19. The method of claim 3 , wherein the molar ratio of lipids to PLB to SERCA is about 100-6000 to 1-10 to 1-10.
20. A kit for identifying a test compound that modulates the SERCA-PLB complex or its microenvironment, comprising:
(a) SERCA labeled with a first chromophore; and
(b) PLB labeled with a second chromophore;
wherein the PLB is WT-PLB or a PLB derivative that gives a FRET potency suitable for HTS, and wherein the chromophores can be used for energy transfer.